The Effects of Asprosin on Exercise-Intervention in Metabolic Diseases

Lifei Liu(Shanghai University of Sport), Jun Zou(Shanghai University of Sport), Jiake Xu(Shenzhen Institutes of Advanced Technology), Xi Chen(Memorial Sloan Kettering Cancer Center), Yuhao Liu(Northeast Agricultural University), Miao Zhang(Shandong University of Traditional Chinese Medicine), Chenyu Zhu(Shanghai University of Sport), Mei Huang(Mianyang City Center for Disease Control and Prevention), Samuel Bennett(Canon (Japan))
Frontiers in Physiology
July 11, 2022
10.3389/fphys.2022.907358
Cited by 26

Related Papers

Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation
|Nature Communications|2016|597
Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference–based bone anabolic strategy
|Nature Medicine|2015|355
Recommendations for Biomarker Identification and Qualification in Clinical Proteomics
|Science Translational Medicine|2010|335
Celastrol induces ROS-mediated apoptosis via directly targeting peroxiredoxin-2 in gastric cancer cells
|Theranostics|2020|299
Pseurotin A Inhibits Osteoclastogenesis and Prevents Ovariectomized-Induced Bone Loss by Suppressing Reactive Oxygen Species
|Theranostics|2019|252